Figure 4.
Kaplan-Meier curves for OS following CAR T-cell therapy failure in different subtypes (transformed DLBCL vs de novo DLBCL vs HGBL), P < .0004. For 4 of the evaluable patients, postrelapse OS could not be assessed as death occurred on the same day as disease progression.